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Background: Caveolin-1 is a fundamental signalling scaffold protein involved in contraction; however, the role of
caveolin-1 in airway responsiveness remains unclear. We evaluated the relationship between caveolin-1 expression in
airway smooth muscle (ASM) and antigen-induced airway responsiveness and obstruction in a guinea pig asthma model.
Methods: Airway obstruction in sensitised guinea pigs, induced by antigenic (ovalbumin) challenges administered
every 10 days, was measured. Antigen-induced responsiveness to histamine and the expression of caveolin-1 and
cavin 1, 2 and 3 were evaluated at the third ovalbumin challenge. The control group received saline solution instead of
ovalbumin.
Results: After the first challenge, antigen exposure induced a transient airway obstruction and airway
hyperresponsiveness, high levels of IL-4 and IL-5 in lung and airway globet cells proliferation at the third antigenic
challenge. Caveolin-1 mRNA levels in total lung decreased in the experimental group compared with controls. Flow
cytometric analysis of ASM from the experimental group showed a high number of cells expressing caveolin-1
compared with controls. This increase was confirmed by western blot. Airway obstruction and hyperresponsiveness
correlated with the degree of increased caveolin-1 expression in ASM cells (P < 0.05; r = 0.69 and −0.52, respectively).
The expression of cavins 1, 2 and 3 in ASM also increased in the experimental group compared to controls.
Immunohistochemical findings reveal that differences in ASM caveolin-1 were not evident between groups.
Nevertheless, a marked decrease in caveolin-1 and caspase 3 was observed in the pulmonary vascular smooth
muscle of asthma model compared with controls. Histological analysis did not reveal differences in smooth
muscles mass or subepithelial fibrosis levels in airways between groups. However, an enlargement of smooth
muscle mass was observed in the pulmonary microvessels of experimental animals. This enlargement did not
induce changes in pulmonary or systemic arterial pressures.
Conclusions: Our data suggest that caveolin-1 expression in ASM has a crucial role in the development of
antigen-induced airway obstruction and hyperresponsiveness in a guinea pig asthma model. In addition, the
asthma model in guinea pigs appears to induce a contractile smooth muscle phenotype in the airways and a
proliferative smooth muscle phenotype in pulmonary vessels.
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Airway smooth muscle is a central structure in asthma
pathogenesis. An important characteristic of asthma is
that numerous stimuli can trigger intense and rapid
bronchospasm in a phenomenon called airway hyperre-
sponsiveness [1,2]. Currently, the precise mechanism by
which the development of hyperresponsiveness is induced
remains unknown. Nevertheless, airway remodelling fea-
tures such as fibrosis and smooth muscle hypertrophy/
hyperplasia have been recognised as playing a part [2].
Caveolin-1 is a hairpin-loop protein that forms omega-
shape invaginations in the plasma membrane, which are
known as caveola [3]. In asthma, a shortage of caveolin-1
has been observed in the airways of asthmatic patients [4].
Similar results have been noted in the lungs of ovalbumin-
challenged mice, where a reduction of caveolin-1 mRNA
expression has been observed [5,6]. In contrast, increased
levels of caveolin-1 are found in the airway smooth muscle
of antigen-challenged in mice [7] and the lungs of guinea
pigs subjected to an asthma model [8].
In airways, caveolin-1 is involved in the downregula-
tion of fibrosis and smooth muscle proliferation [9,10].
However, the role of caveolin-1 in airway hyper-
responsiveness is unclear. The development of airway
hyperresponsiveness in allergen (ovalbumin)-challenged
mice without caveolin-1 has been observed [7,11], and
Hsia and colleagues [12] have found the absence of
caveolin-1 induced airway hyperresponsiveness in endo-
toxin (lipopolysaccharide)-challenged mice. Moreover,
the role of caveolin-1 in airway hyperresponsiveness has
become highly controversial due to the view that
caveolin-1 is related to the regulation of contractile
mechanisms [9,13,14], including, proteins that partici-
pate in intracellular Ca2+ mobilisation [15,16]. For ex-
ample, M3 muscarinic, bradykinin, and H1 histamine
receptors and store-operated Ca2+ entry-regulatory
mechanisms colocalise with caveolin-1 [17]. Addition-
ally, the recruitment of Ca2+ sensitisation components
such as RhoA and PKCα is caveolin-1-dependent
[18,19]. Furthermore, caveolin-1 is a key regulator of
store-operated Ca2+ entry by increasing Orai1 expression
in airway smooth muscle [20].
Since 2005 some proteins named cavins has been asso-
ciated with caveola biogenesis and organization [21]. In
particular, cavin 1 (RNA pol I transcription factor), cavin
2 (serum deprivation protein response) and cavin 3
(SDR- related gene product that binds to C kinase) are
widely expressed in tissues, included smooth muscles
[22]. Recently, it has been observed a decrease in expres-
sion of cavins in airways of caveolin-1 knock-out mice,
although its role in airway contraction its unknown [7].
Experimental asthma models are fundamental in
asthma research. Particularly, guinea pigs asthma model
are susceptible to develop early and late allergicresponses after allergen challenge and also can be used
as a model for chronic allergic asthma [23,24]. Asthma
model in guinea pig is useful since the lung pharmacology
and the response to inflammatory mediators is similar to
humans in comparison to rats and mouse [25,26].
In the current study, we determined the relationship
between caveolin-1 expression and the pathophysio-
logical characteristics of asthma and found that
caveolin-1 expression increases in airway smooth
muscle and that this increase is related to antigen-
induced obstruction and hyperresponsiveness. In con-
trast, pulmonary vascular smooth muscle showed low
expression of caveolin-1, which was accompanied by
smooth muscle cell proliferation.Methods
We used outbred male guinea pigs weighing 0.35-0.4 kg
from Harlan Mexico (strain HsdPoc:DH). The animals
were maintained in our institutional laboratory animal
facilities with filtered air conditioned at 21 ± 1°C and 50-
70% humidity, 12/12-h light/dark cycles, sterilised pellets
(2040 Harlan Teklad Guinea Pig Diet) and water avail-
able ad libitum. All animals were handled according to
protocols approved by the Scientific and Bioethics Com-
mittee of the Instituto Nacional de Enfermedades
Respiratorias.Study design
To determinate the role of caveolin-1 in airway smooth
muscle pathophysiology during asthma, ovalbumin sen-
sitised guinea pigs were exposed to three antigenic
challenges, each administrated every 10 days (Figure 1).
During each challenge, the broncho-obstructive index
was measured. At the third antigenic challenge, the de-
velopment of antigen-induced airway hyperresponsive-
ness was evaluated by performing dose–response
curves to histamine before and after an antigenic chal-
lenge. Animals were then sacrificed to obtain lung and
tracheal samples. In lung samples, caveolin-1 mRNA
was measured by RT-PCR. Additionally, changes in the
amount of collagen in the airway lamina propria and
the extent of airway and pulmonary microvessel
smooth muscle layers were analysed via light micros-
copy. Caveolin-1 expression was examined using immu-
nohistochemistry. Caveolin-1 expression in smooth
muscle cells from tracheae was measured by flow cy-
tometry. Tracheal smooth muscle strips were used to
evaluate the expression of caveolin-1 and cavins 1, 2
and 3 by western blot. Systemic and pulmonary arterial
pressures were measured at the third challenge. Control
animals received sham manoeuvres performed with sa-
line solution.












Figure 1 Experimental design. After initial immunisation and reinforcement with antigen (ovalbumin), guinea pigs received three antigen
challenges. At third challenge the evaluation of broncho-obstructive index, dose–response curves to histamine as well as immunological,
histopathological and vascular function analysis were performed.
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Guinea pigs were sensitised and challenges were per-
formed according to previously described methods
[23,27]. The antigen sensitisation of guinea pigs was
performed by intraperitoneal (0.5 mg/ml) and subder-
mal (0.5 mg/ml) injections with a combination of
60 μg/ml ovalbumin plus 1 mg/ml aluminium hydrox-
ide dispersed in saline solution (Figure 1). The doses
used in sensitisation and challenges in this asthma
model were adjusted to reduce anaphylactic shock dur-
ing challenges. Antigen sensitisation was reinforced eight
days later with ovalbumin aerosol (3 mg/ml saline) deliv-
ered over five minutes. Aerosols were produced by a US-1
Bennett nebuliser (flow, 2 ml/min; Multistage liquid
impinger, Burkard Manufacturing Co., Rickmansworth,
Hertfordshire, UK) releasing mixed particles with sizes
of <4 μm (44%), 4–10 μm (38%), and >10 μm (18%).
From day 15 onward, guinea pigs were challenged over
one minute with an ovalbumin aerosol every 10 days
(1 mg/ml during the first challenge and 0.5 mg/ml in
subsequent challenges) (Figure 1).
Acute airway obstructive responses after ovalbumin
inhalation challenges were recorder using a baromet-
ric plethysmograph. A whole-body single-chamber
plethysmograph for freely moving animals was used
(Buxco Electronics Inc., Troy, NY, USA) to evaluate
pulmonary function. The signal from the chamber was
processed with computer-installed software (Buxco
Bio System XA v1.1) to calculate several respiratory
parameters, including the broncho-obstructive index,
Penh. We calculated this index using the following
equation [28]:Penh = ((Te-Rt)/Rt) (PEP/PIP)
where Te = expiratory time (s), Rt = relaxation time (s),
PEP = peak expiratory pressure (cmH2O), and PIP = peak
inspiratory pressure (cmH2O). The software was
adjusted to include only breaths with a tidal volume of 1
millilitre or more, with minimal inspiratory time of 0.15 sec-
onds, maximal inspiratory time of 3 seconds, and maximal
difference between inspiratory and expiratory volumes of
10%. This guinea pig model of allergic asthma does not
develop a noticeable late airway response. We corroborated
that this sensitisation procedure induces the increment of
Th2 (CD4 + IL13+) lymphocytes in bronchoalveolar lavage.Antigen-induced airway responsiveness
In guinea pigs, airway hyperresponsiveness was mea-
sured after antigen challenge in sensitised (n = 18;
asthma model) and non-sensitised (n = 13; control
group) animals [27]. Airway responsiveness was evalu-
ated on day 35 (third ovalbumin challenge) by exposing
each animal to increasing non-cumulative doses of hista-
mine aerosols (0.001 to 0.32 mg/ml; Sigma Chemical
Co., St. Louis, MO, US) after an initial broncho-
obstructive index acquisition before and after ovalbumin
administration. Each histamine dose was delivered over
1 minute, and the average of the broncho-obstructive
index over the following 10 min was obtained. The inter-
val between doses was 10 min. The dose–response curve
finished when the broncho-obstructive index reached
three times its baseline level. Once the index returned to
the initial baseline value (<50% increment), the ovalbumin
challenge was administered. A second curve was measured
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ovalbumin administration.
Dissection of airway smooth muscle strips for flow
cytometry and Western blot studies
Twenty-four hours after concluding histamine curves,
some sensitised (n = 10) and non-sensitised (n = 9)
guinea pigs were overdosed with an intraperitoneal in-
jection of pentobarbital sodium (65 mg/kg), and their
tracheae were dissected to obtain airway smooth muscle
strips.
Isolation of airway smooth muscle cells
The strips of 7 sensitised and 6 non-sensitised guinea
pigs were incubated at 37°C for 10 min in 5 ml of Hanks’
solution (Gibco, Gaithersburg, MD, US) with 2 mg cyst-
eine and 0.05 U/ml papain (Sigma Chemical Co., St. Louis,
MO, US). The strips were then washed in Leibovitz’s solu-
tion (Gibco, Gaithersburg, MD, US) and placed in a
physiological saline solution (PSS, mM) containing 118
NaCl, 25 NaHCO3, 4.6 KCl, 1.2 MgSO4, 1.2 KH2PO4 and
11 glucose (Sigma Chemical Co., St. Louis, MO, US).
Smooth muscle strips were cut (0.5 x 5 mm), and frag-
ments weighing 200 mg total were placed in 2.5 ml PSS
with collagenase type I (1 mg/ml; Sigma Chemical Co.,
US) and dispase II (4 mg/ml; Sigma Chemical Co., St.
Louis, MO, US) at 37°C. Ten minutes later, the fragments
were transferred to similar PSS containing fresh enzymes.
Tissue was dispersed mechanically until isolated cells were
observed. Leibovitz’s solution was added to stop the en-
zymatic activity.
Flow cytometry
For the detection of caveolin-1 production in the iso-
lated airway smooth muscle cells, a three-color immuno-
fluorescence approach was used following a previously
described method [29]. Isolated myocytes were incu-
bated with 10 μg/ml brefeldin-A (Sigma Chemical Co.;
St. Louis, MO, US) for four hours to inhibit new cyto-
kine release. After staining, cells were washed, fixed with
4% p-formaldehyde for 10 min at 4°C, washed, and per-
meabilised with 0.1% saponin in PBS with 10% BSA and
1% NaN3. Afterwards, cells were gently shaken in the
dark for 15 min at room temperature and 1 μl/1x106
cells were labelled with caveolin-1 antibody (BD Biosci-
ences Pharmingen, San Diego, CA, US). Then, cells were
incubated during 30 min with secondary antibody FITC
mouse (BD Biosciences Pharmingen, San Diego, CA, US).
Finally, cells were analysed for the expression of markers,
on a FACScan flow cytometer (Becton Dickinson, San
Diego, CA, US) using software, and 10,000 events were
counted. To analyse the staining of intracellular caveolin-
1, the blasts were initially gated by their physical proper-
ties (forward and side scatter). A second gate was thendrawn based on the fluorescence characteristics of the
gated cells, assessing fluorescence intensity by histograms.
Intensity of fluorescence staining is expressed as the mean
fluorescence intensity. Control stains were performed
using fluorochrome-conjugated isotype-matched anti-
bodies. Background staining was <1% and subtracted from
experimental values.
Western blot analysis
Smooth muscle strips from guinea pig tracheae (n = 3,
each group) were placed in lysis buffer (1% Triton X-
100, 50 mM Tris, pH 7.4, 150 mM NaCl, 0.1 mM EDTA
and EGTA, 1.0 mM phenylmethylsulfonyl fluoride,
10 μg/ml aprotinin and leupeptin, 1.0 mM Na3VO4, and
50 mM NaF; Sigma Chemical Co.; St. Louis, MO, US)
and homogenised (Polytron PT3100, Kinematica,
Switzerland). Tissue protein (40 μg) from each sample
was loaded in different lanes of a 12% SDS-polyacrylamide
gel. In an additional lane, a control protein (GAPDH;
Sigma Chemical Co.; US) was also added. After electro-
phoretic separation under reducing conditions, proteins
were transferred to a nitrocellulose membrane and
quenched with Tris-buffered saline (TBS) containing 5%
non-fat milk and 0.1% Tween-20. Membranes were sub-
jected to overnight incubation (12 h, 4°C) with rabbit poly-
clonal antibodies raised against caveolin-1 (BD Biosciences
Pharmingen, San Diego CA, US), cavin-1 (Anti/PTRF/
Cavin-1, Millipore, Billerica MA, USA), cavin-2 (SDR,
Thermo Scientific, Rockford IL, USA) and cavin-3
(PRKCDBP, Thermo Scientific, Rockford IL, USA), and
then washed three times with TBS-Tween-20 (0.1%). Cav-
eolin and cavins were detected by adding horseradish
peroxidase-labelled anti-mouse antibodies. Immunoblots
were developed using an enhanced chemiluminescent
reactant (LumiGLO, Cell Signalling; US) and an optimal
exposition of the nitrocellulose sheets to X-ray films (Bio-
max ML Film, Kodak, Rochester, NY US). Caveolin-1 and
cavin immunoblots were analysed by densitometry using
Kodak digital science ID software version 2.03 (Eastman
Kodak, Rochester, NY, US).
RNA isolation
Total RNA from the right lung of some sensitised and
non-sensitised (n = 3, each group) guinea pigs was isolated
following the guanidine isothiocyanate-caesium chloride
method [30]. Total RNA was examined by 1% agarose gel
electrophoresis, and the RNA concentration was deter-
mined by UV light absorbance at 260 nm to evaluate the
integrity of RNA (Beckman DU640, Fullerton, CA, US).
RT-PCR
The relative level of caveolin-1 mRNA expression was
assessed in left lung homogenates by semiquantitative
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mer sequences were custom ordered from GIBCO
BRL (Gaithersburg, MD, US). Sense caveolin-1
primers were amplified to obtain a fragment of 230 bp,
bases 1 to 230 (sense 5′-ATG TCT GGG GGT AAA
TAC GT-3′ and antisense: 5′-CCT TCT GGT TCC
GCA ATC AC-3). A fragment of GAPDH was also
amplified to evaluate or reduce nonspecific effects of
experimental treatment and to semi-quantify caveolin-
1 expression. RNA samples were treated with DNAse
to evaluate genomic DNA contamination relative to
samples passed through a PCR procedure without
adding reverse transcriptase. RT-PCR was carried out
using 2.5 μg of total RNA from lung homogenate. Be-
fore the RT-PCR reaction, total RNA was heated at 65°
C for 10 min. RT-PCR was performed at 37°C for
60 min in a total volume of 20 μl using 200 U of the
Moloney murine leukaemia virus reverse transcriptase
(GIBCO BRL, Gaithersburg, MD, US), 100 pM of ran-
dom hexamers (GIBCO, BRL Gaithersburg, MD, US),
0.5 mM of each dNTP (Sigma, St. Louis, MO, US),
and 1× RT buffer (75 mM KCl, 50 mM Tris · HCl,
3 mM MgCl2, 10 mM DTT, pH 8.3). Samples were
heated at 95°C for 5 min to inactivate the reverse tran-
scriptase and diluted to 40 μl with PCR-grade water.
One-tenth of RT-PCR individual samples from each
group was used for caveolin-1 or GAPDH amplifica-
tion in 20-μl final volume reactions containing 1×
PCR buffer (10 mM Tris · HCl, 1.5 mM MgCl2, 50 mM
KCl, pH 8.3), 0.1 mM of each dNTP, 0.2 μCi of
[α32P]-dCTP (3,000 Ci/mmol, 9.25 MBq, 250 μCi),
10 μM of each primer, and one unit of Taq DNA
polymerase (GIBCO, BRL Gaithersburg, MD, US).
Samples were overlaid with 30 μl of mineral oil and
PCR cycles were performed in a DNA thermal cycler
(M.J. Research, Watertown, MA, US), with the fol-
lowing profile: denaturation for 1 min at 94°C; an-
nealing for 1 min at 55°C and a 1-min extension
step at 72°C. The last cycle was followed by a final
extension step of 5 min at 72°C. Control gene was
co-amplified simultaneously in each reaction. Ampli-
fication kinetics were performed following our stand-
ard procedure [31]. To analyse PCR products, one-
half of each reaction was electrophoresed in a 5%
acrylamide gel. Bands were stained with ethidium
bromide, visualised under UV light, cut out, sus-
pended in 1 ml of scintillation cocktail (Ecolume,
ICN, Aurora, OH, US), and counted by liquid scin-
tillation (Beckman LS6500, Fullerton, CA, US). The
amount of radioactivity recovered from the excised
bands was plotted in a log scale against the number
of cycles. To semi-quantify caveolin-1 and the con-
trol gene, all reactions were performed at least in
quadruplicate.Conventional histology and automated morphometry
analysis
Left caudal lung lobes of some guinea pigs (n = 6, each
group) were dissected and fixed by manual perfusion of
10% neutral buffered formaldehyde solution via intra-
arterial route until the lung lobe was exsanguinated.
Lung fragments obtained by sagittal cutting were em-
bedded in paraffin, and 4 μm-thick lung sections were
stained with Masson trichrome stain. The surface areas
(μm2) of airway smooth muscle and lamina propria, as
well as the vascular smooth muscle of adjacent vessels,
were determined through the use of automated morph-
ometry (Qwin, Leica Microsystems Imaging Solutions,
Cambridge, UK). Data were adjusted by length of the
corresponding basement membrane, and their average
was considered the final result. All measurements were
conducted in six bronchi, six bronchioles and six arteri-
oles (~100 μm diameter) chosen randomly from each
animal. Total epithelial cells in six bronchi of each
guinea pig were counted and the percentage of globet
cell was obtained. The bronchus and bronchiole were
identified by the presence or absence of cartilage in the
airway wall, respectively.ELISA
Anti-human interferon-γ (IFN-γ; R&D System, Minneapolis,
USA), interleukin-4 (IL-4; R&D System, Minneapolis, USA)
and IL-5 (clone TRFK5; BD Pharmingen, USA), antibodies
were used in lung homogenates of sensitized and non sensitised
guinea pigs (n = 6, each group) to measure cytokines by ELISA
as previously described [27].
Immunohistochemistry and immunofluorescence
The same paraffin-embedded lung tissue blocks used for
the morphometric study were used for immunohisto-
chemistry (n = 6, each group) and immunofluorescence
(n = 2, each group). Sections (3 μm) were deparaffinised
(55°C, 30 min) and rehydrated through submersion in
graded alcohols (xylene, 1:1 xylene-alcohol, alcohol, and
70% alcohol for 10 min each, followed by rinsing in dis-
tilled water). Antigen retrieval was performed with
10 mM citrate buffer, pH 6, for 5 min in a microwave
oven. Samples were treated with hydrogen peroxide (3%)
to quench endogenous peroxidase, and nonspecific sites
were blocked later with horse serum (2%). Sections were
incubated at 4°C overnight with an antibody to caveolin-
1 (BD Biosciences Pharmingen, San Diego CA, US). To
detect the specific binding of this primary antibody, an
R.T.U. Vectastain Universal Quick Kit was used (Vector
Laboratories, Inc., Burlingame, CA, USA) in which tissues
were incubated sequentially with blocking serum, a pan-
specific secondary antibody, and streptavidin/peroxidase





































Figure 2 Antigen-induced airway obstruction and responsiveness in sensitised guinea pigs. A) Average of maximum broncho-obstructive index
(Rmax) induced by ovalbumin (closed squares) and saline (open squares) challenges in sensitised guinea pigs. B) PD200 ratio corresponds to PD200 value
observed after antigen challenge divided by PD200 value before challenge. Bars represent mean ± SEM (n= 7 per group). *P< 0.05 compared with control
(repeated measures ANOVA with Dunnett’s multiple comparisons test). +P< 0.05 compared with control (unpaired Student’s t-test).
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were counterstained with Mayer’s haematoxylin. Slides
were rinsed twice with 0.1% Tween-20 phosphate-
buffered saline during the whole process. To control for







































































Figure 3 Cytokine expression and globet cells percentage in sensitize
IL-5 in lung homogenate; B) Globet cell percentage in bronchi. The bars re
compared with control (unpaired Student’s t-test).sections from the same lung were processed without the
primary antibody. No positive staining was observed in
non-specific binding controls. The rabbit IgG (Southern
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Figure 4 Caveolin-1 expression in airway smooth muscle. A) Caveolin-1 mRNA levels in lung (n = 3 in all groups). B) Caveolin-1 expression in
tracheal isolated airway myocytes, measured by flow cytometry (n = 6, 7 for control and asthma model groups). C) Representative autoradiographs
of caveolin-1 and cavins-1, 2 and 3 by western blot in tracheal airway smooth muscle (n = 3 in all groups). Bars represent mean ± SEM. *P < 0.01
compared with control (unpaired Student’s t-test).
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cence, paraffin-embedded tissue was cut 4–6 m thick
and tissue sections were placed in slides and incubated
for 30 min at 55°C. Tissue slides were deparaffinized in
xylenes twice for 10 min each. Hydrate sections grad-
ually through graded alcohols using 2 changes for
10 min each of the following solutions: 100% ethanol,
95% ethanol, and deionized water. For antigen unmask-
ing, slides were covered with 10 mM sodium citrate
buffer, pH 6.0, and heat at 95°C for 5 min. Slides were
then cooled in TBS-T buffer for 20 min at room
temperature. To suppress non-specific binding of anti-
bodies, tissue slides were incubated with 0.2% BSA in
PBS for 20 min at 4°C. After that, immunofluorescence
staining was carried out by overlaying each slide with
20 μl of rabbit polyclonal anti-caspase 3 antibody
(Abcam, San Francisco, CA, USA) for 2 h at 4°C. After
washing in TBS-T buffer for 5 min, a secondary incuba-
tion was performed with fluorescein isothiocyanate
(FITC)-labeled goat anti-rabbit IgG (Jackson Immu-
noResearch Laboratories Inc. Amish Country, PA,
USA) for 30 min at 4°C. After twice washing, slides
were counterstained with fluoroshield mounting
medium with DAPI (Sigma-Aldrich Co, St. Louis, MO,
USA) for nuclei staining (blue channel). All incuba-
tions were carried out in a humidified dark chamber.
In other experiments, tissue slides were incubated
only with FITC-labeled secondary antibody, which was
used as background staining control. Finally, tissue
slides were examined by fluorescence microscope withappropriate filters (Leica DM-LS 2000, Mannheim,
Germany), and analyzed by ImageJ64 software (http://
rsb.info.nih.gov/ij/).Hemodynamic
After 12 h of fasting, some guinea pigs (n = 8 for sensi-
tised, and n = 4 for non-sensitised) were anaesthetised
with isofluorane (1.5%, Sofloran, México, DF) delivered by
a precision vaporiser (Isotec 3, Ohmeda, Steeton, West
Yorkshire, UK) carried in oxygen. Their heart rates were
monitored with an automatic non-invasive device Data-
scope Passport Model EL (Datascope Corp, Mahwah, NJ,
USA), and after deep anaesthesia, animals were ventilated
through a trachea cannula that was connected to both, a
ventilator (Harvard, Rodent Model Ventilator 683) and
the vaporiser. Then, the right carotid artery was dissected,
and a catheter was introduced to measure the systemic ar-
terial pressure and diastolic arterial pressure. A similar
procedure was performed to introduce a catheter into the
pulmonary artery through the right ventricle to determine
the pulmonary arterial pressure. Datascope Passport mon-
itored all pressures.Materials
Ovalbumin (chicken egg albumin) grade II and all stains for
microscopy were purchased from Sigma Chemical Co. (US).
Aluminium hydroxide was purchased from J.T. Baker, USA.






Figure 5 Determination of caveolin-1 expression in control and asthma model guinea pigs by immunohistochemistry. Upper images
(4x) are representative sections of control and asthma model guinea pigs exhibiting caveolin-1 immunostaining in an airway (A) and lung vessel
(V). An amplification of airway and lung vascular smooth muscles is shown in bottom images with arrows. Figures are representative of 6 guinea
pigs in each group.
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Airway responsiveness to histamine was evaluated by means
of the provocative dose 200% (PD200), i.e., the interpolated
histamine dose that caused a three-fold increase of basal
broncho-obstructive index. Change in histamine responsive-
ness induced by antigen challenge was evaluated by the
PD200 ratio, i.e., PD200 value observed after OVA challenge
divided by PD200 value before challenge. In multiple compar-
isons, one-way or repeated-measure ANOVA followed by
Dunnett’s tests was used. Comparison between control and
asthma model groups was evaluated by means of Student’s
unpaired t-test. Associations between caveolin-1 and air-
way responsiveness and obstruction were assessed
through Spearman’s correlation coefficient. Statistical
significance was set at two-tailed P < 0.05. Data in the
text and figures are expressed as the mean ± SEM.
Results and discussion
Antigen-induced airway obstruction and responsiveness
The guinea pig has served as a helpful model in the
study of asthma, with some advantages over othermodels such as the rat and mouse, because it shares
various pharmacological characteristics of human
asthma, besides the strong airway obstructive response
that guinea pigs exhibit after agonist stimulation [32].
Responses to antigen challenge in guinea pig asthma
models are characterised by a rapid and transient airway
obstruction in sensitised animals [23,27]. In the current
study, the values of basal airway obstruction index were
similar between control and experimental groups (data
not shown). Saline challenge did not modify the basal
obstruction index in the control group, but ovalbumin
challenge induced a transient increase in the index that
reached statistical significance in comparison with the
control group (P < 0.05; n = 18 asthma model, and n = 13
control group; Figure 2A).
An important pathophysiological feature of asthma is
the development of airway hyperresponsiveness. In this
study, the basal histamine PD200 value was similar be-
tween the control and experimental groups (data not
shown). In the control group, the histamine PD200 value
after saline challenge was similar to the basal PD200
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ovalbumin challenge was lower than the basal PD200
value. In the control group, the PD200 ratio was signifi-
cantly lower than that obtained in the control group (P <
0.05; n = 18 asthma model, and n = 13 control group;
Figure 2B), implying that all guinea pigs sensitised with
the antigen showed hyperresponsiveness to histamine.
Inflammatory markers in asthma as the Th2 cytokines
IL-4 and IL-5 [33] significantly increases in lung homog-
enates of asthma model guinea pigs in comparison with
controls (P < 0.05; n = 6 each group; Figure 3A). In contrast
IFN-γ, a Th1 cytokine, has similar levels in both groups
(Figure 3A). In addition, a significantly increment of globet
cells was observed in bronchi epithelium of asthma model
group (P < 0.05; n = 6 each group; Figure 3B) suggesting
that this model of acute asthma induces structural changes
in airway epithelium.
Caveolin-1 expression in asthma model
In comparison with other cells, smooth muscle expresses
high levels of caveolin-1 in the plasma membrane [34].
In airway smooth muscle, the signalling platform associated
with caveolin- 1 takes important roles in the recruitment of
various signalling proteins involved in contraction. For ex-
ample, caveolin-1 is involved in Ca2+ homeostasis via the
presence of voltage gated L-type Ca2+ channels, the plasma
membrane Ca2+ ATPase, calsequestrin and calreticulin in
caveolin-enriched membranes [15]. Other components thatA)
B)
Figure 6 Representative histological features of airway in a guinea pi
lungs of control and experimental guinea pigs showing bronchi. B) Area of sm
bronchi (black bars), adjusted by the basement membrane (BM) perimeter, as
± SE of n = 6 per group. *P < 0.01 (unpaired Student’s t-test).play a role in airway smooth muscle contraction, such as
M3 muscarinic, bradykinin, H1 histamine, phospholipase
Cβ1, Gαq and store-operated Ca2+ entry-regulatory mecha-
nisms, co-localise with caveolin-1 [17,35]. Moreover, TNF-
α, a fundamental cytokine in asthma pathogenesis [36], in-
duces RhoA activation, enhances force responses to
acetylcholine, and increases Ca2+ responses to acetyl-
choline, histamine and bradykinin through caveolin-1
upregulation [18,37,38]. Certainly, caveolin-1 is associ-
ated with key molecules that participate in airway
smooth muscle contraction.
In agreement with other studies [4-6], we found that
caveolin-1 is downregulated in the lung homogenates of
experimental animals, as shown in Figure 4A. The level
of caveolin-1 mRNA in the lung homogenate of controls
was significantly higher in comparison to the experimen-
tal group (P < 0.01; n = 3 in all groups); nevertheless,
flow cytometric studies in isolated myocytes demon-
strated that the number of cells that express caveolin-1
increased significantly in the experimental group com-
pared to controls (P < 0.01; n = 6 and 7 for control and
asthma model groups, respectively; Figure 4B). Similar
results in the airway smooth muscle bundles of experi-
mental group animals obtained by immunohistochem-
istry analysis have been described previously [8]. In
our study, we observed that functional changes in the
asthma model correlated with the number of smooth
muscle cells that expressed caveolin-1. The PD200 ratioC)
g allergic asthma model. A) Low-power micrograph (10x) from the
ooth muscle layer and C) lamina propria of bronchioles (white bars) and





























































































Figure 7 Representative histological features of lung vascular smooth muscles in a guinea pig allergic asthma model. A) Low-power
micrograph (10x) from the lungs of control and asthma model guinea pigs showing a bronchus and an arteriole. Note the extensive smooth
muscle (SM) area in the asthma model arteriole. B) Area of arteriole SM layer, as measured by automated morphometry (n = 6 per group). C) Systemic
arterial pressure and D) pulmonary arterial pressures (n = 4 and 8 guinea pigs in control and asthma model group, respectively). Bars and vertical lines
are mean ± SE. *P < 0.01 (unpaired Student’s t-test).
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caveolin-1 (r = −0.517, P < 0.05; n = 13), implying that a
greater number of cells positive for caveolin-1 corre-
sponded to greater antigen-induced airway responsive-
ness. In addition, the Rmax correlated with the number of
cells positive for caveolin-1 (r = 0.691, P < 0.01; n = 13), in-
dicating that antigen-induced airway obstruction is dir-
ectly associated with caveolin-1 in airway smooth muscle
cells.
Western blot analysis detected two specific bands for
caveolin‑1 at approximately 18 to 20 kDa, and the ex-
pression of both bands increased in the experimental
group (Figure 4C; n = 3 all groups). In addition, cavins 1,
2 and 3, a group of proteins that, along with caveolin-1,
regulates caveolae organisation and function [3], were
found in controls but were more highly expressed in the
experimental group (Figure 4C; n = 3 in all groups). Pre-
viously, cavins 1, 2 and 3 have been found to increase in
the airway smooth muscle of ovalbumin-sensitised mice
[7]. Although the role of cavins in asthma is unknown,
TNF-α induced the upregulation of cavins in airwaysmooth muscle, suggesting that inflammation may regu-
late cavin expression [39].
Immunohistochemical images did not reveal notice-
able changes in caveolin-1 staining between controls and
asthma model groups in airway smooth muscle or par-
enchyma (Figure 5; n = 6 all groups); nevertheless a
strong reduction of caveolin-1 expression in vascular
smooth muscle of the experimental group was observed
in comparison with controls (Figure 5). In view that only
pulmonary vascular smooth muscle showed a strong re-
duction in caveolin-1 expression in asthma model, and
the other structures did not exhibit changes, it is pos-
sible that the intense decrease in caveolin-1 mRNA
levels in total lung homogenates (Figure 4A) of the
asthma model was likely produced by the downregulation
of caveolin-1 in this smooth muscle.Airway and lung vascular smooth muscle structure
Airway remodelling has been proposed as an important
factor associated with caveolin in the development of
Álvarez-Santos et al. Clinical and Translational Allergy  (2015) 5:14 Page 11 of 13airway hyperresponsiveness. For example, in a previous
study [23] of a model of chronic asthma in guinea pigs
(nine antigen challenges), we found an association
between subepithelial fibrosis and airway hyperre-
sponsiveness. Caveolin-1 contributes to remodelling
by producing suppressive effects in airway smooth
muscle proliferation [9], likely through the inhibition of
constitutive p42/p44 MAPK activity [40] and by inducing
type I collagen in lung tissue [5]. Airway hyperresponsive-
ness is a consequence of airway remodelling induced by
the lack of caveolin-1 in knock-out mice [7,11].
To evaluate airway remodelling in guinea pigs, Masson
trichrome staining was used to distinguish airway and lung


























Figure 8 Immunofluorescence microscopy showed a significant reduc
blood vessels. Lung tissue sections from guinea pig were incubated with
goat anti-rabbit IgG. Nuclei were counterstained with DAPI and they are show
bronchi either in samples from model asthma or control (upper panels observ
panel, 20x magnification). In contrast, a significant decrease of apoptotic
model. Representative images of at least two independent experiments.cytoplasmic staining (Figures 6A and 7A). Automated
morphometric analysis of smooth muscle mass and sube-
pithelial fibrosis of bronchioles and bronchi did not show
significant differences between control and asthma models
(Figure 6B and C; n = 6 in control and n = 7 in asthma
model groups). In addition, we did not observe an associ-
ation between the degree of hyperresponsiveness and the
level of subepithelial fibrosis (r = 0.25; n = 13) or airway
smooth muscle mass (r = 0.18; n = 13). Nevertheless,
widening of the airway adjacent vessels was observed
(P < 0.05; n = 6 per group; Figure 7A and B). The total
numbers of smooth muscle nuclei in bronchioles in the
experimental and control groups were similar (29 ± 2.3








ed fluorescent staining for caspase 3 in smooth muscle from
rabbit polyclonal anti-caspase 3 antibody, followed by FITC-labeled
n in blue. Caspase 3 positive (apoptotic) cells are uniformly distributed in
ed by 40x magnification) as well as in blood vessel from control (medium
cells in blood vessel smooth muscle cells is observed in asthma
* corresponds to smooth muscle bands in bronchi and lung vessels.
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total smooth muscle cell nuclei from airway adjacent ves-
sels was observed in experimental guinea pigs compared
with controls (51 ± 10.4 and 12 ± 1.2 nuclei, respect-
ively; P < 0.01; n = 6 per group, data not shown). In
addition, caspase 3 expression determinate by immuno-
fluorescence in bronchi smooth muscle did not show
noticeable change in asthma model and control groups;
nevertheless, an evident diminution of caspase 3 ex-
pression was observed in lung smooth muscle from
vessels in asthma model group (n = 2; Figure 8). It sug-
gests that apoptosis is inhibited in vascular smooth
muscle in asthma model, a tissue that also shows a dec-
rement of caveolin-1 expression (Figure 5) and an enlarge-
ment of tissue area (Figure 7B). According to the above,
these findings are in agreement with the antiprolifera-
tive and proapoptotic effects induced by caveolin-1 ob-
served in almost cell types [41]. Then, in conclusion
these results suggest that pulmonary vascular smooth
muscle, but not airway smooth muscle, is capable to
show remodelling changes in acute asthma model in
guinea pigs and that caveolin-1 is associated with this
phenomenom.
Arterial pressure in asthma model
A feature of the contractile, but not proliferative, airway
smooth muscle phenotype is the abundance of caveolae,
suggesting that caveolin-1 may have an inhibitory role in
airway smooth muscle proliferation [9]. In contrast, the
intense diminution of caveolin-1 observed in smooth
muscle from airway adjacent vessels in experimental
guinea pigs appears to be related to the increase in pro-
liferation. In this sense, it is known that caveolin-1 has
a fundamental role in regulating the proliferation of
vascular smooth muscle [42]. In mice, the absence of
caveolin-1 has been shown to modify arterial filling and
increase pulmonary vascular resistance [43]. To deter-
minate the putative physiopathological effect of vascu-
lar smooth muscle hyperplasia on our experimental
guinea pigs, systemic and pulmonary arterial pressures
were evaluated. The experimental and control groups
did not show differences in systemic or pulmonary ar-
terial pressures (n = 4 in control, and n = 8 in asthma
group; Figure 7C and D). Vascular smooth muscle
hyperplasia is observed in asthma patients [44], but this
hyperplasia is unrelated to pulmonary hypertension be-
cause it includes not only hyperplasia of the smooth
muscle but also enhanced vascular contractility and im-
paired vasodilation [45].
Conclusions
Our results suggest that the development of antigen-
induced airway obstruction and hyperresponsiveness is
associated with caveolin-1 expression in airway smoothmuscle in a guinea pig model of asthma. It appears that
the model induces the development of two different
phenotypes, one contractile in airway smooth muscle
and the other proliferative in pulmonary vessels. In
addition, although the asthma model induced a strong
caveolin-1 downregulation in vascular smooth muscle ac-
companied by myocyte proliferation, this phenomenon
did not induce pathophysiological consequences such as
changes in arterial pressure.
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